바이켐

비상장계속사업자

by chem. co.ltd

이범환

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

바이켐

Business Reg. No. 1348103880 · CEO 이범환

I.Investment Overview

Target바이켐 (1348103880)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명바이켐
영문명by chem. co.ltd
대표자이범환
사업자등록번호1348103880
법인등록번호1301110026244
설립일1986.09.01

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW194.32021234.820222362023235.22024222.52025
영업이익100M KRW-4.4202112.8202213.120239.720243.42025
순이익100M KRW-3.7202146.920221020235.420241.52025
Item20252024202320222021
자산총계313.3억원285.3억원287.5억원293.7억원263.2억원
부채총계158.2억원131.7억원139.4억원155.6억원172억원
자본총계155.1억원153.6억원148.1억원138.1억원91.2억원
매출액222.5억원235.2억원236억원234.8억원194.3억원
영업이익3.4억원9.7억원13.1억원12.8억원-4.4억원
순이익1.5억원5.4억원10억원46.9억원-3.7억원

VI.Financial Ratios

FY2025 basis

1.52%

영업이익률

0.66%

순이익률

0.47%

ROA

0.95%

ROE

102.04%

부채비율

49.49%

자기자본비율

VII.R&D Activity

Fields 화공 > 화학공정 · 화학 > 기타 화학

Keywords 희토류, 티탄산바륨, 도료, 분리, 원재료

YearProjectsPapersPatents
2026100
2025100
2024100
2023305
2022300
2021200
2020100
2013000
2012100

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

바이켐 투심보고서 | Alpha Lenz